ArticleHematological oncology2022

Efficacy and follow-up of humanized anti-BCMA CAR-T cell therapy in relapsed/refractory multiple myeloma patients with extramedullary-extraosseous, extramedullary-bone related, and without extramedullary disease.

Wei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.